Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003034978A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034900A2 Sterile, breathable patch for treating wound pain
05/01/2003WO2003008412A3 Hetero-bicyclic crf antagonists
05/01/2003WO2003002152A3 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins
05/01/2003WO2003002109A8 Use of tyrosine kinase inhibitors for treating autoimmune diseases
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002102297A3 Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders
05/01/2003WO2002100351A3 A method for treating inflammatory diseases by administering a ppar-delta agonist
05/01/2003WO2002100335A3 Methods for improving cell line activity in immunoisolation devices
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002098347A3 Methods and compositions that affect melanogenesis (pfi-016cip/pct)
05/01/2003WO2002096435A3 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
05/01/2003WO2002096218A3 Combination of lipoic acids, carnitines, and creatines in food and pharmaceuticals
05/01/2003WO2002090553A3 Recombinant fusion proteins and the trimers thereof
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002089835A3 Pharmaceutical dosage form of amorphous nelfinavir mesylate
05/01/2003WO2002081478A3 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
05/01/2003WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002070548A3 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
05/01/2003WO2002058685A3 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
05/01/2003WO2002051415A3 Use of sequestrants for treating prion diseases
05/01/2003WO2002048165A3 Antiviral agents for treatment of flaviviridae infections
05/01/2003WO2002045704A3 Prevention and treatment of tachyphylactic response
05/01/2003WO2002043739A3 Dermatological formulations containing clindamycin and a zinc-salt
05/01/2003WO2002039995A3 Combination therapy for estrogen-dependent disorders
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003WO2002000244A3 Protein mixtures for wound healing
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083642 Devices and methods for the restoration of a spinal disc
05/01/2003US20030083509 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
05/01/2003US20030083501 Process for preparing paroxetine HCl which limits formation of pink colored compounds
05/01/2003US20030083500 Imidazonaphthyridines
05/01/2003US20030083385 Such as 1-(5-(2-(5-chloro-2-methoxybenzamido)ethyl)-2-(2-methoxyethoxy) -(phenylsulfonyl)-3-methylthiourea; treating cardiovascular disorders
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083374 NAALADase inhibitors useful as pharmaceutical compounds and compositions
05/01/2003US20030083365 Such as 1-(3-(((3,4-dihydro-2H-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1H)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders
05/01/2003US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/01/2003US20030083356 Statine derivatives for the treatment of Alzheimer's disease
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083348 Farnesyl transferase inhibitors
05/01/2003US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury
05/01/2003US20030083344 Tryptase inhibitors
05/01/2003US20030083337 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083325 Serotonin antagonists
05/01/2003US20030083319 For treating osteoporosis, secondary hyperparathyroidism, cancer and autoimmune diseases without inducing hypercalciuria, hypercalcemia, or nephrotoxicity
05/01/2003US20030083315 Benzimidazole derivatives for treating an inflammatory disease, an allergy disease, a respiratory disease, a cardiovascular disorder or a bone disorder
05/01/2003US20030083308 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
05/01/2003US20030083298 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS
05/01/2003US20030083296 Antisense modulation of caspase 8 expression
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083271 Such as 12-(6-deoxy-6-fluoro-D-galactopyranosyl)-3,9-difluoro-12,13-dihydro-5H -indolo(2,3-a)pyrrolo(3,4-c)carbazole -5,7(6H)-dione for inhibiting proliferation of tumor cells
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083262 Methods and compositions for treating inflammatory disorders
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030083228 Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction
05/01/2003US20030082793 Method for preparation of physiologically active water-base extract and method for potentiating the activity thereof
05/01/2003US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same
05/01/2003US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082510 Treatment for viral or bacterial infections of blood; obtain blood sample, incubate with test compound, expose to light, evaluate sample for presence active pathogen
05/01/2003US20030082225 Sterile, breathable patch for treating wound pain
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082184 Uses of mammalian cytokine; related reagents
05/01/2003US20030082180 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
05/01/2003US20030082179 Complexing antibody with poarathyroid hormone
05/01/2003US20030082171 Deafness therapy, prevention; mylein protein vaccine
05/01/2003US20030082169 System and method for the pretreatment of the endplates of an intervertebral disc
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082151 Extension of the expression of transgenic proteins by immunomodulation
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
1 ... 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 ... 1564